Pharmacoeconomics of Systemic and Biologic Therapy in Dermatology

Porter, Martina L.; Kimball, Alexa B.

doi:10.1007/978-3-319-66884-0_10

Cited by 2 publications

(1 citation statement)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The efficiency criterion [11] is applicable by different actors in different areas of healthcare domain. Recent international experiences [12,13,14,15] The economic evaluation of medicines usually employs the traditional methods of economic analysis [16], which means that all professionals working in the field and interacting information from it need basic knowledge of the terms and concepts that are currently the common denominator of both economic evaluation and health economics. For this reason, pharmacoeconomics is an activity that requires multidisciplinary teams and, in fact, a high proportion of analysts who carry out studies in this field are not economists but come from the field of health sciences, statistics, operational research, etc., and have often not had a formal apprenticeship in economic disciplines.…”

Section: Pharmacoeconomics and Economic Evaluations Within Healthmentioning

confidence: 99%

Pharmacoeconomics as a Management and Financial Strategy in Healthcare and Simulation as a Decision Making Tool for It The Case of Ozone Therapy

Remondino

Franzini

2018

International Journal of Simulation: Systems, Science &Amp; Technology

View full text Add to dashboard Cite

Pharmacoeconomics can play a very important role in decision-making for healthcare structures. In fact, it consists of economic evaluation of drugs and treatments for specific diseases. Several techniques exist for this, mainly based on traditional management and financial methods as, for example: cost-minimization analysis, cost-benefit analysis, cost-effectiveness analysis or cost-utility analysis. The present paper proposes the use of agent based process simulation as an additional tool to assess the pharmacoeconomic analysis, in which to incorporate traditional financial tools. This technique allows to compare different treatments ceteris paribus, that is by simulating the effects of different drugs and treatments on the same patient, by comparing both the medical effects and the economic and financial effects. Last, the paper proposes the case of ozone therapy as a powerful use case for this simulative approach, since ozone, a natural gas with antibacterial and anti-inflammatory properties, can successfully be used to treat many diseases as an alternative to other drugs and treatments.

show abstract